Nivolumab Maintenance Therapy After Autologous Stem Cell Transplant in Hodgkin Lymphoma Pts at Relapse/Progression Risk
Clinical trial NCT03436862 · COMPLETED
Trial details
- NCT number
- NCT03436862
- Sponsor
- SCRI Development Innovations, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-23
- Primary completion
- 2022-05-05
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.